share_log

4: Statement of changes in beneficial ownership of securities-Director McMullen Michael R.

4: Statement of changes in beneficial ownership of securities-Director McMullen Michael R.

4:持股變動聲明-董事 McMullen Michael R.
美股SEC公告 ·  07/03 05:37
牛牛AI助理已提取核心訊息
Michael R. McMullen, associated with Bristol-Myers Squibb Co. [BMY], was involved in a transaction on 07/01/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. As such, the impact of this event on McMullen's holdings and the overall market position of Bristol-Myers Squibb remains unclear.
Michael R. McMullen, associated with Bristol-Myers Squibb Co. [BMY], was involved in a transaction on 07/01/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. As such, the impact of this event on McMullen's holdings and the overall market position of Bristol-Myers Squibb remains unclear.
與施貴寶公司[BMY]有關的Michael R. McMullen在2024年07月01日進行了一項交易。公告未披露該交易的具體細節,包括操作類型、狀態幣、涉及的股份數量、股份性質、交易價格和發帖後持股情況。因此,這一事件對於McMullen的持股和施貴寶的整體市場地位的影響仍不清楚。
與施貴寶公司[BMY]有關的Michael R. McMullen在2024年07月01日進行了一項交易。公告未披露該交易的具體細節,包括操作類型、狀態幣、涉及的股份數量、股份性質、交易價格和發帖後持股情況。因此,這一事件對於McMullen的持股和施貴寶的整體市場地位的影響仍不清楚。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。